2023 changes to FIGO endometrial cancer staging: Counterpoint Editorial

  

Author:	Leitao, M. M. Jr
Title:	2023 changes to FIGO endometrial cancer staging: Counterpoint
Keywords:	immunohistochemistry; cancer survival; survival rate; sequence analysis; review; cancer recurrence; cancer staging; cancer diagnosis; hysterectomy; pelvis lymph node; endometrium cancer; sentinel lymph node; progression free survival; protein p53; risk factor; mismatch repair; microsatellite instability; physician; world health organization; pathologist; ploidy; cancer prognosis; human; female; clinical audit
Journal Title:	Gynecologic Oncology
Volume:	184
ISSN:	0090-8258
Publisher:	Elsevier Inc.
Date Published:	2024-05-01
Start Page:	146
End Page:	149
Language:	English
DOI:	10.1016/j.ygyno.2024.01.040
PUBMED:	38309032
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85184024794&doi=10.1016%2fj.ygyno.2024.01.040&partnerID=40&md5=38e7d4f2ca524d28e630f0dc06b4df6a
Notes:	Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/213873